Related Experiment Videos

Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a

James J Jang1, Aron I Schwarcz, Daniel A Amaez

  • 1Zena and Michael A Wiener Cardiovascular Institute and Marie-Joseìe and Henry R Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, New York, USA. james.j.jang@kp.org

Insights

Peripheral arterial disease (PAD) affects 11% of young HIV-infected patients. Traditional risk factors and elevated osteoprotegerin levels are linked to PAD, suggesting early screening is crucial.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Immunology

Background:

  • HIV infection is linked to accelerated atherosclerosis and increased cardiovascular disease risk.
  • Elevated osteoprotegerin levels are associated with cardiovascular events and mortality.
  • Peripheral arterial disease (PAD) is a significant manifestation of cardiovascular disease.

Purpose of the Study:

  • To determine the prevalence of PAD in HIV-infected individuals.
  • To identify associations between PAD and HIV-specific/traditional cardiovascular risk factors.
  • To investigate the relationship between PAD and osteoprotegerin levels in this population.

Main Methods:

  • A cross-sectional study involving 102 HIV-infected patients.
  • Ankle-brachial indices (ABIs) were measured to assess PAD prevalence.
  • Medical history and laboratory data were collected to identify risk factors.

Main Results:

  • PAD prevalence was 11% in the HIV-infected cohort (mean age 48).
  • Traditional risk factors (age, prior cardiovascular history, CRP) were associated with PAD.
  • Elevated osteoprotegerin levels were observed in patients with high ABIs compared to those with normal ABIs.

Conclusions:

  • A significant prevalence of PAD exists in young HIV-infected patients.
  • PAD in this population is associated with traditional cardiovascular risk factors and elevated osteoprotegerin.
  • Early screening and proactive management of PAD are recommended for HIV-infected individuals.
Abstract

Related Concept Videos